RNA‐DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next‐Generation Therapeutics

We introduce RNA-DNA fusomers, a new class of chemically synthesized oligonucleotides that combine the versatile properties of RNA and DNA within a single sequence and self-assemble into higher-order functional structures via a simple one-pot annealing reaction. This hybrid platform allows precise customization with therapeutic nucleic acids, offering tunable physicochemical, mechanical, and immunological properties, cost-effective production, and the capacity to integrate biological functionalities intrinsic to both RNA and DNA. The modular architecture of fusomers enables straightforward optimization for diverse biomedical applications, including gene silencing, anti-inflammatory therapy, anticoagulation, antibacterial activity, and protein biosensing. We demonstrate efficient delivery and intracellular modulation by fusomers in multiple model systems, including human peripheral blood mononuclear cells isolated from healthy human donors and 3D organ-on-a-chip models. Molecular dynamics simulations further elucidate the structural behavior of fusomers and their intended interactions with protein targets. Collectively, these findings position fusomers as a next-generation therapeutic platform with broad transformative potential.

Authors

Institutions

Publication Details

Journal
Small
Published
2026-06-09
DOI
https://doi.org/10.1002/smll.202600078
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RNA‐DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next‐Generation Therapeutics

Yelixza I. Avila, Morgan Chandler, Ian Marriott, Elizabeth Skelly et al.
Small
Advanced biosensing and bioanalysis techniques
article

RNA‐DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next‐Generation Therapeutics

Yelixza I. Avila, Morgan Chandler, Ian Marriott, Elizabeth Skelly, Kirill A. Afonin, Marina A. Dobrovolskaia, Hemani Chhabra, Yasmine Radwan, Laura P. Rebolledo, Lauren Rackley, Renata de Freitas Saito, Roger Chammas, Alexander Lushnikov, Alexey V. Krasnoslobodtsev, Tatiane Katsue Furuya, Julio Navas Hernandez, Edward Cedrone, Ana Luiza Lomba, Aleksei Aksimentiev, Laxmi K. Pandey, Meni Wanunu, Da Shi
article en

Abstract

We introduce RNA-DNA fusomers, a new class of chemically synthesized oligonucleotides that combine the versatile properties of RNA and DNA within a single sequence and self-assemble into higher-order functional structures via a simple one-pot annealing reaction. This hybrid platform allows precise customization with therapeutic nucleic acids, offering tunable physicochemical, mechanical, and immunological properties, cost-effective production, and the capacity to integrate biological functionalities intrinsic to both RNA and DNA. The modular architecture of fusomers enables straightforward optimization for diverse biomedical applications, including gene silencing, anti-inflammatory therapy, anticoagulation, antibacterial activity, and protein biosensing. We demonstrate efficient delivery and intracellular modulation by fusomers in multiple model systems, including human peripheral blood mononuclear cells isolated from healthy human donors and 3D organ-on-a-chip models. Molecular dynamics simulations further elucidate the structural behavior of fusomers and their intended interactions with protein targets. Collectively, these findings position fusomers as a next-generation therapeutic platform with broad transformative potential.

Small
University of North Carolina at Charlotte (US), University of Nebraska at Omaha (US), Northeastern University (US), University of Illinois Urbana-Champaign (US), Universidade de São Paulo (BR), Instituto do Câncer do Estado de São Paulo (BR), Frederick National Laboratory for Cancer Research (US), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Biological Mimetics (United States) (US)
U.S. Department of Health and Human Services, National Institutes of Health, Division of Molecular and Cellular Biosciences
Openalex Percentile: Top 10%
Advanced biosensing and bioanalysis techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.